INTRODUCTION: The objectives of this study were to estimate the prevalence of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) among injection drug users (IDUs) and identify the sociodemographic and behavioral factors in this population associated with these infections. METHODS: Cross-sectional study in IDUs recruited in Catalonia in 2006. RESULTS: Ever-sharing syringes was associated with both HIV and HCV infection. Indirect sharing of injecting equipment and injecting cocaine as the main drug were factors associated with HCV infection, and the fact of having injected in prison was associated with HIV infection. CONCLUSION: Identification of sociodemographic and behavioral factors associated with these infections can be of help when designing specific preventive interventions for IDUs. Copyright 2008 Elsevier España, S.L. All rights reserved.
INTRODUCTION: The objectives of this study were to estimate the prevalence of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) among injection drug users (IDUs) and identify the sociodemographic and behavioral factors in this population associated with these infections. METHODS: Cross-sectional study in IDUs recruited in Catalonia in 2006. RESULTS: Ever-sharing syringes was associated with both HIV and HCV infection. Indirect sharing of injecting equipment and injecting cocaine as the main drug were factors associated with HCV infection, and the fact of having injected in prison was associated with HIV infection. CONCLUSION: Identification of sociodemographic and behavioral factors associated with these infections can be of help when designing specific preventive interventions for IDUs. Copyright 2008 Elsevier España, S.L. All rights reserved.
Authors: M Florencia Etcheverry; Paula J Lum; Jennifer L Evans; Emilia Sanchez; Elisa de Lazzari; Eva Mendez-Arancibia; Ernesto Sierra; José M Gatell; Kimberly Page; Joan Joseph Journal: Vaccine Date: 2011-01-15 Impact factor: 3.641
Authors: David Toro-Tobón; Dedsy Berbesi-Fernandez; Pedro Mateu-Gelabert; Ángela M Segura-Cardona; Liliana P Montoya-Vélez Journal: Int J Drug Policy Date: 2018-08-11
Authors: Lucas Wiessing; Marica Ferri; Bart Grady; Maria Kantzanou; Ida Sperle; Katelyn J Cullen; Angelos Hatzakis; Maria Prins; Peter Vickerman; Jeffrey V Lazarus; Vivian D Hope; Catharina Matheï Journal: PLoS One Date: 2014-07-28 Impact factor: 3.240
Authors: Annemarie Rinder Stengaard; Lauren Combs; Virginie Supervie; Sara Croxford; Sarika Desai; Ann K Sullivan; Stine Finne Jakobsen; Quenia Santos; Daniel Simões; Jordi Casabona; Jeffrey V Lazarus; John B F de Wit; Frank M Amort; Anastasia Pharris; Lina Nerlander; Dorthe Raben Journal: Euro Surveill Date: 2021-11
Authors: Juliana Reyes-Urueña; M Teresa Brugal; Xavier Majo; Antonia Domingo-Salvany; Joan A Caylà Journal: BMC Public Health Date: 2015-11-13 Impact factor: 3.295